BIO-GATE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.025 EUR | -2.38% |
|
-0.99% | -5.66% |
| 2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
| Sales 2023 * | 7M 7.44M | Sales 2024 * | 8.21M 8.73M | Capitalization | 9.7M 10.32M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 1.39 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.18 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 38 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 48.3% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.38% | ||
| 1 week | -0.99% | ||
| 1 month | -9.91% | ||
| 3 months | +5.26% | ||
| Current year | -5.66% |
1 week
1.00
1.14
1 month
1.001.19
Current year
0.911.38
1 year
0.582.22
3 years
0.585.00
5 years
0.585.00
10 years
0.585.00
| Managers | Title | Age | Since |
|---|---|---|---|
Marc Lloret-Grau
CEO | Chief Executive Officer | - | 12-01-07 |
Thomas Konradt
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Volker Rofalski
BRD | Director/Board Member | 54 | 11-12-31 |
Karl Richter
CHM | Chairman | - | - |
Volker Alt
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 1 | -4.76% | 0 |
| 24-04-15 | 1.05 | +5.00% | 148 |
| 24-04-12 | 1 | -1.96% | 0 |
| 24-04-11 | 1.02 | 0.00% | 0 |
| 24-04-10 | 1.02 | +0.99% | 0 |
Delayed Quote Deutsche Boerse AG, April 16, 2024 at 03:15 am EDT
More quotes
Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The Company incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.66% | 10.32M | |
| -1.07% | 189B | |
| -2.61% | 107B | |
| -3.74% | 67.81B | |
| +8.44% | 51.87B | |
| +14.04% | 46.67B | |
| -0.77% | 38.68B | |
| +7.58% | 27.73B | |
| +2.52% | 26.6B | |
| +5.14% | 26.34B |
- Stock Market
- Equities
- BIG1 Stock
